11C-methionine uptake and intraoperative 5-aminolevulinic acid-induced fluorescence as separate index markers of cell density in glioma: A stereotactic image-histological analysis

Cancer

Volumn 118, Issue 6, 2012, Pages 1619-1627

  Arita, Hideyuki ^a   Kinoshita, Manabu ^a   Kagawa, Naoki ^a   Fujimoto, Yasunori ^a   Kishima, Haruhiko ^a   Hashimoto, Naoya ^a   Yoshimine, Toshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 aminolevulinic acid; 11C methionine; glioma; positron emission tomography; tumor cell density

Indexed keywords

AMINOLEVULINIC ACID; KI 67 ANTIGEN; METHIONINE C 11; PROTOPORPHYRIN; CARBON; DIAGNOSTIC AGENT; METHIONINE;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CANCER STAGING; CELL DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; FLUORESCENCE ANALYSIS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STEREOTACTIC BIOPSY; TUMOR CELL; BRAIN TUMOR; CELL COUNT; CHEMISTRY; FLUORESCENCE; GLIOMA; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; AMINOLEVULINIC ACID; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CELL COUNT; CELL PROLIFERATION; FEMALE; FLUORESCENCE; GLIOMA; HUMANS; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROTOPORPHYRINS; REGRESSION ANALYSIS;

EID: 84858000629     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26445     Document Type: Article

References (42)

1. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008; 63: 700-707; author reply 707-708.
2. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009; 110: 156-162.
3. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95: 190-198. (Pubitemid 32799739)
4. Pichlmeier U, Bink A, Schackert G, Stummer W,. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 2008; 10: 1025-1034.
5. Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res. 2004; 10: 7163-7170. (Pubitemid 39487701)
6. Watanabe M, Tanaka R, Takeda N,. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology. 1992; 34: 463-469.
7. Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L,. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol. 2006; 27: 1432-1437. (Pubitemid 44260122)
8. Galldiks N, Kracht LW, Burghaus L, et al. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur J Nucl Med Mol Imaging. 2006; 33: 516-524.
9. Grosu AL, Weber WA, Riedel E, et al. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys. 2005; 63: 64-74. (Pubitemid 41583543)
10. Kato T, Shinoda J, Nakayama N, et al. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol. 2008; 29: 1176-1182. (Pubitemid 351954890)
11. Kim S, Chung JK, Im SH, et al. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2005; 32: 52-59. (Pubitemid 40142778)
12. Nariai T, Tanaka Y, Wakimoto H, et al. Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg. 2005; 103: 498-507. (Pubitemid 43186642)
13. Padma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol. 2003; 64: 227-237. (Pubitemid 37203463)
14. Ribom D, Eriksson A, Hartman M, et al. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer. 2001; 92: 1541-1549. (Pubitemid 32947840)
15. Ribom D, Schoenmaekers M, Engler H, Smits A,. Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas. J Neurooncol. 2005; 71: 325-332. (Pubitemid 40372965)
16. Ullrich RT, Kracht L, Brunn A, et al. Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J Nucl Med. 2009; 50: 1962-1968.
17. Pirotte BJ, Levivier M, Goldman S, et al. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery. 2009; 64: 471-481; discussion 481.
18. Regula J, MacRobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX-a pilot study. Gut. 1995; 36: 67-75.
19. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ,. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7: 392-401.
20. Berger G, Maziere M, Knipper R, Prenant C, Comar D,. Automated synthesis of 11C-labelled radiopharmaceuticals: imipramine, chlorpromazine, nicotine and methionine. Int J Appl Radiat Isot. 1979; 30: 393-399. (Pubitemid 9238660)
21. Veninga T, Huisman H, van der Maazen RW, Huizenga H,. Clinical validation of the normalized mutual information method for registration of CT and MR images in radiotherapy of brain tumors. J Appl Clin Med Phys. 2004; 5: 66-79.
22. Okita Y, Kinoshita M, Goto T, et al. (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage. 2010; 49: 2977-2982.
23. Kinoshita M, Hynynen K,. Mechanism of porphyrin-induced sonodynamic effect: possible role of hyperthermia. Radiat Res. 2006; 165: 299-306.
24. Kinoshita M, Hashimoto N, Goto T, et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage. 2008; 43: 29-35.
25. Feigl GC, Ritz R, Moraes M, et al. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg. 2010; 113: 352-357.
26. Hayashi Y, Nakada M, Tanaka S, Uchiyama N, Kita D, Hamada J,. Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases. J Neurosurg. 2010; 112: 1015-1019.
27. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H,. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a 1-year experience at a single institutuion. Swiss Med Wkly. 2008; 138: 180-185.
28. Nabavi A, Thurm H, Zountsas B, et al. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase II study. Neurosurgery. 2009; 65: 1070-1076; discussion 1076-1077.
29. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ,. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000; 93: 1003-1013. (Pubitemid 32800611)
30. Tanaka Y, Nariai T, Momose T, et al. Glioma surgery using a multimodal navigation system with integrated metabolic images. J Neurosurg. 2009; 110: 163-172.
31. Pirotte B, Goldman S, Van Bogaert P, et al. Integration of [11C]methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumors in children. Neurosurgery. 2005; 57: 128-139; discussion 128-139.
32. Hatazawa J, Ishiwata K, Itoh M, et al. Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography. J Nucl Med. 1989; 30: 1809-1813. (Pubitemid 19279784)
33. Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging. 2008; 30: 868-873. (Pubitemid 36734206)
34. Kato T, Shinoda J, Oka N, et al. Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity. AJNR Am J Neuroradiol. 2008; 29: 1867-1871.
35. Nojiri T, Nariai T, Aoyagi M, et al. Contributions of biological tumor parameters to the incorporation rate of L-[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas. J Neurooncol. 2009; 93: 233-241.
36. Torii K, Tsuyuguchi N, Kawabe J, Sunada I, Hara M, Shiomi S,. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med. 2005; 19: 677-683. (Pubitemid 43175528)
37. Roberts DW, Valdes PA, Harris BT, et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. J Neurosurg. 2011; 114: 595-603.
38. Floeth FW, Sabel M, Ewelt C, et al. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging. 2011; 38: 731-741.
39. Stockhammer F, Misch M, Horn P, Koch A, Fonyuy N, Plotkin M,. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas. Acta Neurochir (Wien). 2009; 151: 1377-1383.
40. Widhalm G, Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer. 2010; 116: 1545-1552.
41. Duffner F, Ritz R, Freudenstein D, Weller M, Dietz K, Wessels J,. Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX. J Neurooncol. 2005; 71: 107-111. (Pubitemid 40796290)
42. Eleouet S, Rousset N, Carre J, et al. Heterogeneity of delta-aminolevulinic acid-induced protoporphyrin IX fluorescence in human glioma cells and leukemic lymphocytes. Neurol Res. 2000; 22: 361-368. (Pubitemid 30409593)